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Protamine 1 and two protamine 2 variants were isolated from stallion sperm and separated by acetic acid-urea gel electro- 
phoresis. After electroblotting onto polyvinyldifluoride filters, their amino-terminal amino acid sequences were deter- 
mined by pulse-liquid peptide sequencing. The sequences of the two protamine 2 variants are homologous but slightly 
different in length and amino acid composition and indicate for the first time the existence of two different genes for 
this protamine species. 
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1. INTRODUCTION 
During sperm cell differentiation, histones in the 
cell nucleus are replaced by protamines, which are 
small arginine-rich proteins. The protamines have 
a role in packaging sperm DNA to a highly con- 
densed, stable and inactive complex. All mam- 
malian sperm examined thus far have been found 
to contain protamine 1. The complete amino acid 
sequences of protamine 1 from bull [l], boar [2], 
ram 131, stallion [4,5], human [6,7], and mouse [8] 
have been determined. In the different species 
studied, there exists a strong sequence homology in 
this protein. 
Certain species including mouse [8], hamster [9], 
human [lo], and horse [4] contain a second pro- 
tamine variant, protamine 2, which differs in size 
and amino acid composition from protamine 1. In 
contrast to protamine 1, mouse protamine 2 is syn- 
thesized as a testicular precursor [l 1’1. 
We have isolated the protamines from stallion 
spermatozoa and found three protamines: pro- 
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tamine 1 and two protamine 2 variants. When the 
amino-terminal amino acid sequences of the pro- 
tamine 2 variants were determined, the sequences 
were found to be different in length and in amino 
acid composition indicating in stallion sperm the 
existence of different but homologous genes for 
these variants. 
2. MATERIALS AND METHODS 
2.1. Semen collection 
Semen samples were collected from Finnhorse stallions used 
for artificial insemination at the State Horse Breeding Institute, 
Ypajija, Finland. Two to three first fractions of the ejaculates 
were obtained using an open-ended artificial vagina. Washed 
sperm cells were stored at -20°C. 
2.2. Isolation of basic nuclear proteins 
The isolation procedure was a modification of the methods 
described by Balhorn et al. [12] and Ammer and Henschen [5]. 
Approx. 8 x 10’ sperm cells were extracted with 2 ml of 1% 
acetic acid for 15 min at room temperature and collected by 
centrifugation at 1500 x g. The pellet was extracted with 2 ml 
of 8 M guanidine hydrochloride (GuHCI) containing 0.1 M Li- 
acetate, pH 4, and 1 mM phenylmethylsulphonyl fluoride 
(PMSF) using sonication (Labsonic 2000) with two 10 s bursts 
at 50 W. After incubation for 15 min at room temperature, the 
nuclei were collected by centrifugation and washed twice with 
distilled water. 
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The chromatin was solubilized by adding 1 ml of 5 M GuHCI 
containing 0.5 M Tris-HCl, pH 8. After incubation for 5 min 
at 37”C, the chromatin proteins were dissociated by adding 
urea, mercaptoethanol, NaCl, and PMSF to a final concentra- 
tion of 0.5 M, 0.5 M, 2 M, and 1 mM, respectively. The solu- 
tion was incubated for 1 h at 37°C and the DNA precipitated 
by adding HCl to 0.5 M. After 1 h at 4”C, the DNA was cen- 
trifuged for 15 min at 17000 x g. The supernatant was dialyzed 
overnight against 0.01 M HCl in Spectrapor-3 tubing (Spectrum 
Medical Industries, Los Angeles, USA). Protein concentration 
of the dialysate was measured using a protein assay kit from 
Bio-Rad Laboratories (Richmond, CA, USA) with bovine 
serum albumin as a standard. 
The lyophilized protamines were reduced with a 38-fold 
molar excess of dithiothreitol (DTT) over protamine cysteine in 
0.5 M Tris-HCl, pH 8, 5 M GuHCl, and 2 mM EDTA for 1 h 
at room temperature and alkylated with iodoacetamide (2-fold 
excess over DTT) for 1 h at dark. Alkylated protamines were 
dialyzed for 2 h against 0.01 M HCl in Spectrapor-3 tubing and 
lyophilized before electrophoresis. GuHCl, Li-acetate, PMSF, 
DTT and iodoacetamide were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). 
2.3. Polyacrylamide gel electrophoresis, electroblotting and 
protein sequencing 
The alkylated protamines were separated by acetic acid-urea 
slab gels [13] containing 20% acrylamide, 0.13% bisacrylamide, 
and 2.5 M urea. The stacking gel and the sample buffer de- 
scribed by Spiker (141 were used. All reagents for the elec- 
trophoresis were purchased from Bio-Rad Laboratories. After 
electrophoresis, the protamines were electroblotted at 4°C onto 
polyvinyldifluoride (PVDF) filters (Immobilon, Millipore Inc., 
Boston, USA) for 1 h at 70 V using a Trans-BlotTM-apparatus 
from Bio-Rad Laboratories. The transfer buffer was 2.5% 
acetic acid. The proteins were then stained with a solution con- 
taining 0.1% Amido Black, 45% methanol, and 10% acetic 
acid. The stained bands were cut out and stored at - 20°C until 
sequencing. The amino-terminal sequences were determined 
directly from the filters using an Applied Biosystems 477A pulse 
liquid protein/peptide sequencer with a 120A PTH analyzer 
[ISI. 
3. RESULTS 
Total nuclear proteins from stallion sperm were 
isolated using three extraction steps. About 4 mg 
of protein was obtained from 8 x 10’ sperm cells. 
The alkylated protamines were separated by acetic 
acid-urea gel electrophoresis. Three bands were 
seen on the gel (fig.1). Immediately after elec- 
trophoresis, the separated protamines were 
transferred onto a PVDF-filter. The major band 
(band 1) was further cut into 2 mm x 4 mm pieces 
and submitted to sequencing. Pieces from 3 to 6 
bands were combined for analysis of the minor 
protamines (bands 2 and 3). 
When the amino-terminal amino acids (20 
200 
Fig. 1. Acetic acid-polyacrylamide gel electrophoresis of 
alkylated stallion protamines. 2Opg of total protein was 
dissolved in the sample buffer and electrophoresed for 2 h at 
200 V (stacking gel) and for 3 h at 150 V (running gel). The gel 
was stained with a solution containing 0.1% Serva Blau R, 50% 
methanol, and 10% acetic acid. 
residues) of the major band (band 1) were deter- 
mined, the sequence was found to be identical with 
that of the major protamine (Stl) from stallion 
sperm [4]. The amino-terminal sequences of the 
two other protamines (bands 2 and 3) were analyz- 
ed twice (25 cycles; fig.2) and the proteins were 
named protamine St2b and St2a, respectively. The 
St2 variants were found to be homologous proteins 
with a difference in amino-terminal length and 
amino acid sequence (three residues). 
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StZa ARTTAGSY&BYRRR&CSPRRLYRLR-- 
StPb AGSYYSYRRRRCSPRRLYRLRRRRY-- 
HP2 RTHGQSH- -YRRRHCSRRRLHRI HRRQH- - 
HP3 GQS H - -YRRRHCS-- 
pnpz- - GRTHRGHHH -HRHRRCSRKRLHRIHKR-R-- 
ml?? RGHHH-HRHRRCS-- 
Fig.2. The amino-terminal amino acid sequences of the two protamine 2 variants from stallion sperm. The sequences are aligned with 
corresponding sequences of human protamines (HP2 and HP3) [19], mouse protamine 2 (mP2) [&I], and the testicular precursor of 
mouse protamine 2 (pmP2) (residues 40-67) [l 11. Non-homologous regions of stallion protamines are underlined. 
4. DISCUSSION 
Recent studies on cDNAs of mouse protamine 1 
(mP1) and protamine 2 (mP2) [16,17] as well as 
amino acid sequences of protamines from other 
species [l-7] indicate that most mammals have a 
protamine species with a strong homology to mP1 
cDNA. In contrast, the expression of protamine 2 
gene varies greatly among different species. For in- 
stance, protamine 2 has never been detected from 
rat by gel electrophoresis, although a gene se- 
quence with strong homology to mP2 cDNA has 
been described [ 161. The same situation occurs in 
bull and boar spermatozoa, both of which contain 
a single protamine but also appear to have a pro- 
tamine gene homologous to mP2 cDNA. In 
stallion epididymal spermatozoa, no hybridization 
signal for mP2 cDNA has been detected [ 161. 
Using polyacrylamide electrophoresis including 
7.5% stacking gel and 20% running gel, a better 
resolution was achieved than with methods 
previously used for separation of basic nuclear 
proteins from sperm [13]. Three protamines from 
stallion spermatozoa were separated for sequence 
analysis. The major component of the basic pro- 
teins turned out to be protamine 1, since we found 
an amino-terminal sequence identical with that 
published previously [4]. 
A protamine 2 family with at least four variants 
(HP2, HP3, HPSl, and HPS2) differing only in 
the length of their amino-termini [19] has been 
detected by gel electrophoresis from mature 
human spermatozoa [18]. The intermediate pro- 
teins HPSl and HPS2 are probably precursors of 
HP2 and HP3. There is a strong sequence 
homology between human protamine 2 variants 
and the testicular precursor of mouse protamine 2 
[ 191. These pro-protamines of mature human sper- 
matozoa are probably products of one protamine 
2 gene and represent different steps in the post- 
translational maturation process. 
Sequence analysis of the two minor protamines 
from stallion sperm indicates that these proteins 
belong to the protamine 2 family. The 25 amino- 
terminal residues determined representing almost 
one half of the length of the proteins indicate a 
close structural relationship with human HP2 and 
HP3 and mouse mP2. Several conservative 
changes in the amino acid sequence of different 
species can be explained by single point mutations 
in protamine 2 gene. The lack of histidine and 
abundance of tyrosine are typical of the amino- 
terminal amino acid composition of the protamine 
2 variants. 
The two protamine 2 variants from stallion 
sperm differ from each other not only in their 
amino-terminal engths but also in residues 9, 10, 
and 15 in St2a (5, 6, and 11 in St2b). In positions 
10 and 15 in St2a (6 and 11 in St2b), the amino acid 
differences may have resulted from gene duplica- 
tion followed by point mutations. The changes 
(Arg-Ser and Cys-Arg) are, however, not conser- 
vative in nature. Serine residues in protamines may 
participate in phosphorylation-dephosphorylation 
reactions, which seem to be involved in the process 
of packaging of chromatin and cysteine may par- 
ticipate in disulfide bridge formation. These non- 
conservative changes in the amino acid sequence of 
the protamine variants may thus cause differences 
in their binding characteristics and function. Final- 
ly, a change of Arg to Tyr in position 9 in St2a (5 
in St2b) must have involved more than one point 
mutation. 
In conclusion, according to the amino-terminal 
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amino acid sequence analysis of two protamine 2 
variants, there are two different but homologous 
protamine 2 genes in stallion spermatozoa, which 
could have arisen by gene duplication and subse- 
quent point mutations. The horse seems to be the 
only species thus far reported with two different 
genes for protamine 2. 
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